Author

Yu Jung Kim

Seoul National UniversityORCID 0000-0002-5037-0523Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:phylogenetics / evolution· 1

Frequent Co-Authors

Jee Hyun KimiD· 3 shared Jin Won KimiD· 3 shared Koung Jin SuhiD· 3 shared Se Hyun KimiD· 3 shared Eun Hee JungiD· 2 shared Hee Young NaiD· 2 shared Keun‐Wook LeeiD· 2 shared Kui‐Jin KimiD· 2 shared

Activity by Year

2022-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 44 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Jee Hyun KimORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCancer Gene TherapyPeer-reviewedOct 31, 2026

Loss of p21-activated kinase 4 (PAK4) suppresses pancreatic tumor progression and metastasis through regulating E-cadherin

Kui‐Jin Kim, Cheng Hyun Lee, Hee Young Na…·Jin Won Kim

This study shows that PAK4 promotes pancreatic cancer metastasis by reducing E-cadherin, and its loss inhibits tumor progression and metastasis.

DOI 10.1038/s41417-026-01091-y

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 16, 2025

VEGFR2 blockade overcomes acquired KRAS G12D inhibitor resistance driven by PI3Kγ activation

Sung‐Hyun Hwang, Mingyun Bae, Ji‐Won Kim…·Keun‐Wook Lee

This paper identifies VEGFA-VEGFR2 signaling driven by PI3Kγ activation as a mechanism of acquired resistance to KRAS G12D inhibitors and shows that blocking this pathway restores drug sensitivity in resistant cancer models.

DOI 10.1101/2025.09.16.676456

𝕏 PostBluesky

GeneticseLifePeer-reviewedDec 8, 2022

Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors

Min-Su Kang, Hee Young Na, Soomin Ahn…·Ho‐Seong Han

This study traces the evolutionary paths of gallbladder adenocarcinomas, showing subclonal diversification and selection from precancerous lesions to metastatic tumors.

15 citations

humanwhole-exome sequencing

𝕏 PostBluesky